Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

Improving Deep Sleep in Older Adults May Lower Dementia Risk
News
Improving Deep Sleep in Older Adults May Lower Dementia Risk
11/20/2023
Each percentage decrease in slow-wave sleep per year in people 60 years and older is associated with a 27% increased risk of dementia, according to study results published in JAMA Neurology. “Slow-wave sleep, or deep sleep, supports the...
Each percentage decrease in slow-wave sleep per year in people 60 years and older is associated with a 27% increased risk of dementia, according to study results published in JAMA Neurology. “Slow-wave sleep, or deep sleep, supports the...
Each percentage decrease in...
11/20/2023
Neurology
a depressed woman looks at her phone while sitting on a bus, train
News
Severe Mental Illness Upped Risk of Death After Positive COVID-19 Test
11/14/2023
During the first year of the pandemic, people with severe mental illness (SMI) had a 50% greater risk of all-cause death following COVID-19 infection compared to people without serious mental illness.
During the first year of the pandemic, people with severe mental illness (SMI) had a 50% greater risk of all-cause death following COVID-19 infection compared to people without serious mental illness.
During the first year of the...
11/14/2023
Neurology

Advertisement

News
AF Risk Increases Over Time in Patients With Stroke Attributed to LAD, SVD
11/14/2023
Atrial fibrillation detection rose from 12.5% at 1 year to 21.7% in 3 years in patients with stroke attributed to large-artery atherosclerotic disease and small-vessel occlusive disease who were monitored with an insertable cardiac monitor.
Atrial fibrillation detection rose from 12.5% at 1 year to 21.7% in 3 years in patients with stroke attributed to large-artery atherosclerotic disease and small-vessel occlusive disease who were monitored with an insertable cardiac monitor.
Atrial fibrillation detection...
11/14/2023
Neurology
Effectiveness of Non Pharmacological Interventions in Preventing Delirium Among Older Adults
News
Effectiveness of Non Pharmacological Interventions in Preventing Delirium Among Older Adults
11/09/2023
Results from an overview of systematic reviews about non pharmacological interventions in preventing and treating delirium among older people were published in the International Journal of Nursing Studies.
Results from an overview of systematic reviews about non pharmacological interventions in preventing and treating delirium among older people were published in the International Journal of Nursing Studies.
Results from an overview of...
11/09/2023
Psych Congress Network
A little girl sleeps with her mouth hanging open
News
Regular Snoozers Appear to Benefit From Putting Off Morning Rise
11/08/2023
Hitting the snooze button for 30 minutes in the morning slightly improved or did not affect cognitive performance upon waking in habitual snoozers, according to research published in the Journal of Sleep Research.
Hitting the snooze button for 30 minutes in the morning slightly improved or did not affect cognitive performance upon waking in habitual snoozers, according to research published in the Journal of Sleep Research.
Hitting the snooze button for 30...
11/08/2023
Neurology

Advertisement

a profile of a head with a heart over where the brain would be
News
Viral Persistence, Reduced Serotonin May Explain Long Covid Symptoms
11/02/2023
Post-acute sequelae of COVID-19, commonly referred to as long COVID symptoms, are associated with reduced levels of the neurotransmitter serotonin, according to study findings published in the journal Cell.
Post-acute sequelae of COVID-19, commonly referred to as long COVID symptoms, are associated with reduced levels of the neurotransmitter serotonin, according to study findings published in the journal Cell.
Post-acute sequelae of COVID-19,...
11/02/2023
Neurology
Alzheimer Dementia Odor Sensitivity
News
APOE ε4 Affects Odor Sensitivity and May Help Predict Cognitive Decline
11/02/2023
Assessing odor sensitivity could provide an early indicator of impending cognitive impairment, according to recent study findings published in the journal Neurology.
Assessing odor sensitivity could provide an early indicator of impending cognitive impairment, according to recent study findings published in the journal Neurology.
Assessing odor sensitivity could...
11/02/2023
Psych Congress Network
No Evidence Stroke, Hypertension Mediates Link Between Air Pollution and Dementia
News
No Evidence Stroke, Hypertension Mediates Link Between Air Pollution and Dementia
10/23/2023
Hypertension and stroke do not mediate or modify the association between exposure to fine particulate matter air pollution (PM2.5) with incident dementia, according to study results published online in JAMA Network Open. “Although we...
Hypertension and stroke do not mediate or modify the association between exposure to fine particulate matter air pollution (PM2.5) with incident dementia, according to study results published online in JAMA Network Open. “Although we...
Hypertension and stroke do not...
10/23/2023
Neurology

Advertisement

Steven R. Chan, MD, MBA.
Updates in Psychiatry
DEA Extends Temporary Telehealth Prescribing Rules but Long-Term Investment Needed, Expert Says
10/20/2023
The US Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) jointly announced on October 6 that telehealth prescribing flexibilities will continue through December 31, 2024.
The US Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) jointly announced on October 6 that telehealth prescribing flexibilities will continue through December 31, 2024.
The US Drug Enforcement...
10/20/2023
Psych Congress Network
An illustrated picture shows two cartoon doctors, one holding up a magnifying glass to a cartoon brain.
News
No Disease Activity in Two-Thirds of Patients With Relapsing-Remitting MS a Decade After Stem Cell Therapy
10/19/2023
More than half of patients with relapsing-remitting multiple sclerosis (MS) who underwent autologous hematopoietic stem cell transplantation (aHSCT) experienced improved disability.
More than half of patients with relapsing-remitting multiple sclerosis (MS) who underwent autologous hematopoietic stem cell transplantation (aHSCT) experienced improved disability.
More than half of patients with...
10/19/2023
Neurology

Advertisement

Advertisement

News

Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology
Hands holding a head in profile with an illustrated heart over brain
News
Antiseizure Meds May Increase Cardiovascular Risk in Older Adults With Epilepsy
10/21/2024
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy...
10/21/2024
Neurology
FDA approval stamp
News
FDA Approves Infusion Treatment for Advanced Parkinson Disease in Adults
10/18/2024
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa...
10/18/2024
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
News
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
10/15/2024
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to...
10/15/2024
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use